Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MNOV | US
-0.05
-2.43%
Healthcare
Biotechnology
30/06/2024
17/10/2024
1.80
1.76
1.83
1.75
MediciNova Inc. a biopharmaceutical company focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast) an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders such as primary and secondary progressive multiple sclerosis amyotrophic lateral sclerosis chemotherapy-induced peripheral neuropathy degenerative cervical myelopathy glioblastoma and substance dependence and addiction. The company's product pipeline also includes MN-221 (bedoradrine) a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast) an orally bioavailable small molecule compound to treat fibrotic and other diseases including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin) a tubulin binding agent for treating solid tumor cancers. It has collaboration agreements with Kissei Pharmaceutical Co. Ltd.; Kyorin Pharmaceutical Co. Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. The company was incorporated in 2000 and is headquartered in La Jolla California.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
54.4%1 month
92.2%3 months
87.7%6 months
70.0%-
-
1.52
0.01
0.01
-2.65
43.15
-0.94
-9.80M
88.53M
88.53M
-
-981.95
-
-
-13.32
2.47
0.47
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.37
Range1M
0.55
Range3M
1.03
Rel. volume
0.68
Price X volume
28.90K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
GENELUX CORP | GNLX | Biotechnology | 2.81 | 97.04M | -9.06% | n/a | 5.86% |
BeyondSpring Inc | BYSI | Biotechnology | 2.39 | 96.32M | 0.00% | n/a | -14.90% |
Marinus Pharmaceuticals Inc | MRNS | Biotechnology | 1.74 | 95.85M | -3.33% | n/a | -202.54% |
bluebird bio Inc | BLUE | Biotechnology | 0.4865 | 94.34M | 0.98% | n/a | 736.91% |
HilleVax Inc | HLVX | Biotechnology | 1.87 | 93.10M | 2.75% | n/a | 24.92% |
InflaRx N.V | IFRX | Biotechnology | 1.55 | 91.27M | 2.65% | n/a | 0.00% |
Tiziana Life Sciences PLC | TLSA | Biotechnology | 0.896 | 90.96M | 1.82% | n/a | 0.00% |
CytomX Therapeutics Inc | CTMX | Biotechnology | 1.16 | 90.62M | -1.69% | 7.67 | -37.61% |
Werewolf Therapeutics Inc. Common Stock | HOWL | Biotechnology | 2.05 | 89.59M | -0.49% | n/a | 35.26% |
BioAtla Inc. | BCAB | Biotechnology | 1.85 | 89.42M | -5.61% | n/a | 5.30% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 32.05 | 92.04M | -1.35% | 5.27 | 19.82% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14.35 | 89.85M | 0.07% | 14.47 | 7.10% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -2.65 | 0.53 | Cheaper |
Ent. to Revenue | 43.15 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 1.52 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 87.74 | 72.92 | Riskier |
Debt to Equity | 0.01 | -1.24 | Expensive |
Debt to Assets | 0.01 | 0.25 | Cheaper |
Market Cap | 88.53M | 3.78B | Emerging |